nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—CA14—Furosemide—dilated cardiomyopathy	0.352	0.438	CbGbCtD
Zoledronate—CA12—Furosemide—dilated cardiomyopathy	0.25	0.311	CbGbCtD
Zoledronate—CA2—Furosemide—dilated cardiomyopathy	0.202	0.251	CbGbCtD
Zoledronate—GGPS1—cardiac ventricle—dilated cardiomyopathy	0.00746	0.137	CbGeAlD
Zoledronate—GGPS1—myocardium—dilated cardiomyopathy	0.00701	0.129	CbGeAlD
Zoledronate—Breast cancer—Spironolactone—dilated cardiomyopathy	0.00609	0.0427	CcSEcCtD
Zoledronate—Anxiety depression—Lisinopril—dilated cardiomyopathy	0.00553	0.0388	CcSEcCtD
Zoledronate—GGPS1—heart—dilated cardiomyopathy	0.0049	0.0903	CbGeAlD
Zoledronate—CA14—cardiac ventricle—dilated cardiomyopathy	0.00446	0.0822	CbGeAlD
Zoledronate—GGPS1—cardiac atrium—dilated cardiomyopathy	0.00419	0.0772	CbGeAlD
Zoledronate—Tetany—Furosemide—dilated cardiomyopathy	0.00371	0.026	CcSEcCtD
Zoledronate—Cardiac fibrillation—Lisinopril—dilated cardiomyopathy	0.00348	0.0244	CcSEcCtD
Zoledronate—FDPS—cardiac ventricle—dilated cardiomyopathy	0.00344	0.0634	CbGeAlD
Zoledronate—Shoulder pain—Lisinopril—dilated cardiomyopathy	0.00337	0.0236	CcSEcCtD
Zoledronate—FDPS—myocardium—dilated cardiomyopathy	0.00323	0.0596	CbGeAlD
Zoledronate—CA14—heart—dilated cardiomyopathy	0.00293	0.054	CbGeAlD
Zoledronate—CA14—cardiac atrium—dilated cardiomyopathy	0.0025	0.0461	CbGeAlD
Zoledronate—Atrial flutter—Lisinopril—dilated cardiomyopathy	0.00239	0.0167	CcSEcCtD
Zoledronate—FDPS—heart—dilated cardiomyopathy	0.00226	0.0416	CbGeAlD
Zoledronate—Flank pain—Lisinopril—dilated cardiomyopathy	0.00225	0.0158	CcSEcCtD
Zoledronate—Local reaction—Furosemide—dilated cardiomyopathy	0.00218	0.0153	CcSEcCtD
Zoledronate—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00218	0.0153	CcSEcCtD
Zoledronate—FDPS—cardiac atrium—dilated cardiomyopathy	0.00193	0.0356	CbGeAlD
Zoledronate—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.0019	0.0134	CcSEcCtD
Zoledronate—ABCC1—myocardium—dilated cardiomyopathy	0.00188	0.0346	CbGeAlD
Zoledronate—CA2—cardiac ventricle—dilated cardiomyopathy	0.00178	0.0329	CbGeAlD
Zoledronate—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00175	0.0123	CcSEcCtD
Zoledronate—Azotaemia—Lisinopril—dilated cardiomyopathy	0.0017	0.0119	CcSEcCtD
Zoledronate—CA2—myocardium—dilated cardiomyopathy	0.00168	0.0309	CbGeAlD
Zoledronate—Lethargy—Spironolactone—dilated cardiomyopathy	0.00165	0.0116	CcSEcCtD
Zoledronate—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00162	0.0114	CcSEcCtD
Zoledronate—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00145	0.0102	CcSEcCtD
Zoledronate—Gastritis—Spironolactone—dilated cardiomyopathy	0.00143	0.01	CcSEcCtD
Zoledronate—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.00132	0.00927	CcSEcCtD
Zoledronate—ABCC1—heart—dilated cardiomyopathy	0.00131	0.0242	CbGeAlD
Zoledronate—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00127	0.00891	CcSEcCtD
Zoledronate—Throat sore—Lisinopril—dilated cardiomyopathy	0.00126	0.00883	CcSEcCtD
Zoledronate—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00125	0.00875	CcSEcCtD
Zoledronate—Renal failure—Spironolactone—dilated cardiomyopathy	0.00122	0.00858	CcSEcCtD
Zoledronate—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00118	0.00831	CcSEcCtD
Zoledronate—CA2—heart—dilated cardiomyopathy	0.00117	0.0216	CbGeAlD
Zoledronate—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00116	0.00814	CcSEcCtD
Zoledronate—ABCC1—cardiac atrium—dilated cardiomyopathy	0.00112	0.0207	CbGeAlD
Zoledronate—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00103	0.00724	CcSEcCtD
Zoledronate—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00102	0.00714	CcSEcCtD
Zoledronate—CA2—cardiac atrium—dilated cardiomyopathy	0.001	0.0185	CbGeAlD
Zoledronate—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000998	0.007	CcSEcCtD
Zoledronate—Swelling—Furosemide—dilated cardiomyopathy	0.000995	0.00698	CcSEcCtD
Zoledronate—Alopecia—Spironolactone—dilated cardiomyopathy	0.000986	0.00692	CcSEcCtD
Zoledronate—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000934	0.00655	CcSEcCtD
Zoledronate—Thirst—Furosemide—dilated cardiomyopathy	0.000922	0.00647	CcSEcCtD
Zoledronate—Neck pain—Lisinopril—dilated cardiomyopathy	0.000918	0.00644	CcSEcCtD
Zoledronate—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000918	0.00644	CcSEcCtD
Zoledronate—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000901	0.00633	CcSEcCtD
Zoledronate—Lethargy—Furosemide—dilated cardiomyopathy	0.000896	0.00628	CcSEcCtD
Zoledronate—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000891	0.00625	CcSEcCtD
Zoledronate—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000881	0.00618	CcSEcCtD
Zoledronate—Malaise—Spironolactone—dilated cardiomyopathy	0.000876	0.00615	CcSEcCtD
Zoledronate—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00087	0.0061	CcSEcCtD
Zoledronate—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000856	0.00601	CcSEcCtD
Zoledronate—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000822	0.00577	CcSEcCtD
Zoledronate—Discomfort—Spironolactone—dilated cardiomyopathy	0.000817	0.00573	CcSEcCtD
Zoledronate—Dehydration—Furosemide—dilated cardiomyopathy	0.000816	0.00573	CcSEcCtD
Zoledronate—Confusional state—Spironolactone—dilated cardiomyopathy	0.000799	0.00561	CcSEcCtD
Zoledronate—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000799	0.0056	CcSEcCtD
Zoledronate—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000793	0.00556	CcSEcCtD
Zoledronate—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00079	0.00555	CcSEcCtD
Zoledronate—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000776	0.00545	CcSEcCtD
Zoledronate—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000774	0.00543	CcSEcCtD
Zoledronate—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000764	0.00536	CcSEcCtD
Zoledronate—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000761	0.00534	CcSEcCtD
Zoledronate—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000713	0.00501	CcSEcCtD
Zoledronate—Somnolence—Spironolactone—dilated cardiomyopathy	0.000705	0.00495	CcSEcCtD
Zoledronate—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000701	0.00492	CcSEcCtD
Zoledronate—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000695	0.00488	CcSEcCtD
Zoledronate—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000692	0.00486	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000685	0.0048	CcSEcCtD
Zoledronate—Arthritis—Lisinopril—dilated cardiomyopathy	0.000678	0.00475	CcSEcCtD
Zoledronate—Renal failure—Furosemide—dilated cardiomyopathy	0.000665	0.00467	CcSEcCtD
Zoledronate—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000659	0.00462	CcSEcCtD
Zoledronate—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000659	0.00462	CcSEcCtD
Zoledronate—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000653	0.00458	CcSEcCtD
Zoledronate—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000631	0.00443	CcSEcCtD
Zoledronate—Urticaria—Spironolactone—dilated cardiomyopathy	0.00063	0.00442	CcSEcCtD
Zoledronate—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000627	0.0044	CcSEcCtD
Zoledronate—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000617	0.00433	CcSEcCtD
Zoledronate—Dehydration—Lisinopril—dilated cardiomyopathy	0.000612	0.0043	CcSEcCtD
Zoledronate—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.0006	0.00421	CcSEcCtD
Zoledronate—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000595	0.00418	CcSEcCtD
Zoledronate—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000593	0.00416	CcSEcCtD
Zoledronate—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000589	0.00413	CcSEcCtD
Zoledronate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000584	0.0041	CcSEcCtD
Zoledronate—Gastritis—Lisinopril—dilated cardiomyopathy	0.000583	0.00409	CcSEcCtD
Zoledronate—Asthma—Lisinopril—dilated cardiomyopathy	0.000569	0.00399	CcSEcCtD
Zoledronate—Influenza—Lisinopril—dilated cardiomyopathy	0.000569	0.00399	CcSEcCtD
Zoledronate—Eye disorder—Furosemide—dilated cardiomyopathy	0.000567	0.00398	CcSEcCtD
Zoledronate—Pruritus—Spironolactone—dilated cardiomyopathy	0.000561	0.00394	CcSEcCtD
Zoledronate—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00056	0.00393	CcSEcCtD
Zoledronate—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000554	0.00389	CcSEcCtD
Zoledronate—Angiopathy—Furosemide—dilated cardiomyopathy	0.000551	0.00387	CcSEcCtD
Zoledronate—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000548	0.00385	CcSEcCtD
Zoledronate—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000543	0.00381	CcSEcCtD
Zoledronate—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000542	0.00381	CcSEcCtD
Zoledronate—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000541	0.00379	CcSEcCtD
Zoledronate—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000532	0.00373	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000529	0.00371	CcSEcCtD
Zoledronate—Erythema—Furosemide—dilated cardiomyopathy	0.000529	0.00371	CcSEcCtD
Zoledronate—Malnutrition—Furosemide—dilated cardiomyopathy	0.000529	0.00371	CcSEcCtD
Zoledronate—Dizziness—Spironolactone—dilated cardiomyopathy	0.000524	0.00368	CcSEcCtD
Zoledronate—Weight increased—Lisinopril—dilated cardiomyopathy	0.000518	0.00363	CcSEcCtD
Zoledronate—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000518	0.00363	CcSEcCtD
Zoledronate—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000515	0.00361	CcSEcCtD
Zoledronate—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000508	0.00357	CcSEcCtD
Zoledronate—Depression—Lisinopril—dilated cardiomyopathy	0.000506	0.00355	CcSEcCtD
Zoledronate—Vomiting—Spironolactone—dilated cardiomyopathy	0.000504	0.00354	CcSEcCtD
Zoledronate—Rash—Spironolactone—dilated cardiomyopathy	0.0005	0.00351	CcSEcCtD
Zoledronate—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000499	0.0035	CcSEcCtD
Zoledronate—Renal failure—Lisinopril—dilated cardiomyopathy	0.000499	0.0035	CcSEcCtD
Zoledronate—Vision blurred—Furosemide—dilated cardiomyopathy	0.000498	0.0035	CcSEcCtD
Zoledronate—Headache—Spironolactone—dilated cardiomyopathy	0.000497	0.00349	CcSEcCtD
Zoledronate—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000493	0.00346	CcSEcCtD
Zoledronate—Anaemia—Furosemide—dilated cardiomyopathy	0.000489	0.00343	CcSEcCtD
Zoledronate—Agitation—Furosemide—dilated cardiomyopathy	0.000486	0.00341	CcSEcCtD
Zoledronate—Haematuria—Lisinopril—dilated cardiomyopathy	0.000484	0.0034	CcSEcCtD
Zoledronate—Vertigo—Furosemide—dilated cardiomyopathy	0.000475	0.00333	CcSEcCtD
Zoledronate—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000474	0.00332	CcSEcCtD
Zoledronate—Leukopenia—Furosemide—dilated cardiomyopathy	0.000473	0.00332	CcSEcCtD
Zoledronate—Nausea—Spironolactone—dilated cardiomyopathy	0.000471	0.0033	CcSEcCtD
Zoledronate—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000464	0.00325	CcSEcCtD
Zoledronate—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00045	0.00316	CcSEcCtD
Zoledronate—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000449	0.00315	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000447	0.00314	CcSEcCtD
Zoledronate—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000447	0.00313	CcSEcCtD
Zoledronate—Dry mouth—Furosemide—dilated cardiomyopathy	0.00044	0.00309	CcSEcCtD
Zoledronate—Confusional state—Furosemide—dilated cardiomyopathy	0.000435	0.00305	CcSEcCtD
Zoledronate—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000431	0.00303	CcSEcCtD
Zoledronate—Shock—Furosemide—dilated cardiomyopathy	0.000424	0.00298	CcSEcCtD
Zoledronate—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000423	0.00297	CcSEcCtD
Zoledronate—Flushing—Lisinopril—dilated cardiomyopathy	0.000423	0.00297	CcSEcCtD
Zoledronate—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000422	0.00296	CcSEcCtD
Zoledronate—Skin disorder—Furosemide—dilated cardiomyopathy	0.000419	0.00294	CcSEcCtD
Zoledronate—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000417	0.00293	CcSEcCtD
Zoledronate—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000413	0.0029	CcSEcCtD
Zoledronate—Anorexia—Furosemide—dilated cardiomyopathy	0.000411	0.00289	CcSEcCtD
Zoledronate—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000411	0.00288	CcSEcCtD
Zoledronate—Chills—Lisinopril—dilated cardiomyopathy	0.000409	0.00287	CcSEcCtD
Zoledronate—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000407	0.00286	CcSEcCtD
Zoledronate—Hypotension—Furosemide—dilated cardiomyopathy	0.000403	0.00283	CcSEcCtD
Zoledronate—Alopecia—Lisinopril—dilated cardiomyopathy	0.000403	0.00282	CcSEcCtD
Zoledronate—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000399	0.0028	CcSEcCtD
Zoledronate—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000397	0.00278	CcSEcCtD
Zoledronate—Erythema—Lisinopril—dilated cardiomyopathy	0.000397	0.00278	CcSEcCtD
Zoledronate—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000388	0.00273	CcSEcCtD
Zoledronate—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000387	0.00272	CcSEcCtD
Zoledronate—Back pain—Lisinopril—dilated cardiomyopathy	0.000384	0.00269	CcSEcCtD
Zoledronate—Somnolence—Furosemide—dilated cardiomyopathy	0.000383	0.00269	CcSEcCtD
Zoledronate—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000381	0.00268	CcSEcCtD
Zoledronate—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000375	0.00263	CcSEcCtD
Zoledronate—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000374	0.00262	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000372	0.00261	CcSEcCtD
Zoledronate—Fatigue—Furosemide—dilated cardiomyopathy	0.000372	0.00261	CcSEcCtD
Zoledronate—Tremor—Lisinopril—dilated cardiomyopathy	0.000372	0.00261	CcSEcCtD
Zoledronate—Constipation—Furosemide—dilated cardiomyopathy	0.000369	0.00259	CcSEcCtD
Zoledronate—Pain—Furosemide—dilated cardiomyopathy	0.000369	0.00259	CcSEcCtD
Zoledronate—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000368	0.00258	CcSEcCtD
Zoledronate—Anaemia—Lisinopril—dilated cardiomyopathy	0.000367	0.00257	CcSEcCtD
Zoledronate—Angioedema—Lisinopril—dilated cardiomyopathy	0.000362	0.00254	CcSEcCtD
Zoledronate—Malaise—Lisinopril—dilated cardiomyopathy	0.000358	0.00251	CcSEcCtD
Zoledronate—Vertigo—Lisinopril—dilated cardiomyopathy	0.000356	0.0025	CcSEcCtD
Zoledronate—Syncope—Lisinopril—dilated cardiomyopathy	0.000356	0.0025	CcSEcCtD
Zoledronate—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000355	0.00249	CcSEcCtD
Zoledronate—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000355	0.00249	CcSEcCtD
Zoledronate—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000353	0.00248	CcSEcCtD
Zoledronate—Palpitations—Lisinopril—dilated cardiomyopathy	0.00035	0.00246	CcSEcCtD
Zoledronate—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000349	0.00245	CcSEcCtD
Zoledronate—Cough—Lisinopril—dilated cardiomyopathy	0.000346	0.00243	CcSEcCtD
Zoledronate—Urticaria—Furosemide—dilated cardiomyopathy	0.000343	0.0024	CcSEcCtD
Zoledronate—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000341	0.00239	CcSEcCtD
Zoledronate—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000341	0.00239	CcSEcCtD
Zoledronate—Myalgia—Lisinopril—dilated cardiomyopathy	0.000338	0.00237	CcSEcCtD
Zoledronate—Chest pain—Lisinopril—dilated cardiomyopathy	0.000338	0.00237	CcSEcCtD
Zoledronate—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000338	0.00237	CcSEcCtD
Zoledronate—Anxiety—Lisinopril—dilated cardiomyopathy	0.000336	0.00236	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000335	0.00235	CcSEcCtD
Zoledronate—Discomfort—Lisinopril—dilated cardiomyopathy	0.000334	0.00234	CcSEcCtD
Zoledronate—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00033	0.00232	CcSEcCtD
Zoledronate—Confusional state—Lisinopril—dilated cardiomyopathy	0.000326	0.00229	CcSEcCtD
Zoledronate—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000324	0.00227	CcSEcCtD
Zoledronate—Oedema—Lisinopril—dilated cardiomyopathy	0.000324	0.00227	CcSEcCtD
Zoledronate—Infection—Lisinopril—dilated cardiomyopathy	0.000322	0.00226	CcSEcCtD
Zoledronate—Shock—Lisinopril—dilated cardiomyopathy	0.000318	0.00223	CcSEcCtD
Zoledronate—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000318	0.00223	CcSEcCtD
Zoledronate—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000317	0.00222	CcSEcCtD
Zoledronate—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000316	0.00222	CcSEcCtD
Zoledronate—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000314	0.00221	CcSEcCtD
Zoledronate—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000313	0.0022	CcSEcCtD
Zoledronate—Asthenia—Furosemide—dilated cardiomyopathy	0.00031	0.00217	CcSEcCtD
Zoledronate—Anorexia—Lisinopril—dilated cardiomyopathy	0.000309	0.00216	CcSEcCtD
Zoledronate—Pruritus—Furosemide—dilated cardiomyopathy	0.000305	0.00214	CcSEcCtD
Zoledronate—Hypotension—Lisinopril—dilated cardiomyopathy	0.000302	0.00212	CcSEcCtD
Zoledronate—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000295	0.00207	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000295	0.00207	CcSEcCtD
Zoledronate—Insomnia—Lisinopril—dilated cardiomyopathy	0.000293	0.00205	CcSEcCtD
Zoledronate—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000291	0.00204	CcSEcCtD
Zoledronate—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000289	0.00202	CcSEcCtD
Zoledronate—Somnolence—Lisinopril—dilated cardiomyopathy	0.000288	0.00202	CcSEcCtD
Zoledronate—Dizziness—Furosemide—dilated cardiomyopathy	0.000285	0.002	CcSEcCtD
Zoledronate—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000285	0.002	CcSEcCtD
Zoledronate—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000281	0.00197	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000279	0.00196	CcSEcCtD
Zoledronate—Fatigue—Lisinopril—dilated cardiomyopathy	0.000279	0.00196	CcSEcCtD
Zoledronate—Pain—Lisinopril—dilated cardiomyopathy	0.000277	0.00194	CcSEcCtD
Zoledronate—Constipation—Lisinopril—dilated cardiomyopathy	0.000277	0.00194	CcSEcCtD
Zoledronate—Vomiting—Furosemide—dilated cardiomyopathy	0.000274	0.00192	CcSEcCtD
Zoledronate—Rash—Furosemide—dilated cardiomyopathy	0.000272	0.00191	CcSEcCtD
Zoledronate—Dermatitis—Furosemide—dilated cardiomyopathy	0.000272	0.00191	CcSEcCtD
Zoledronate—Headache—Furosemide—dilated cardiomyopathy	0.00027	0.0019	CcSEcCtD
Zoledronate—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000267	0.00187	CcSEcCtD
Zoledronate—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000265	0.00186	CcSEcCtD
Zoledronate—Urticaria—Lisinopril—dilated cardiomyopathy	0.000257	0.0018	CcSEcCtD
Zoledronate—Nausea—Furosemide—dilated cardiomyopathy	0.000256	0.0018	CcSEcCtD
Zoledronate—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000256	0.0018	CcSEcCtD
Zoledronate—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000256	0.0018	CcSEcCtD
Zoledronate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000238	0.00167	CcSEcCtD
Zoledronate—Asthenia—Lisinopril—dilated cardiomyopathy	0.000232	0.00163	CcSEcCtD
Zoledronate—Pruritus—Lisinopril—dilated cardiomyopathy	0.000229	0.00161	CcSEcCtD
Zoledronate—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000221	0.00155	CcSEcCtD
Zoledronate—Dizziness—Lisinopril—dilated cardiomyopathy	0.000214	0.0015	CcSEcCtD
Zoledronate—Vomiting—Lisinopril—dilated cardiomyopathy	0.000206	0.00144	CcSEcCtD
Zoledronate—Rash—Lisinopril—dilated cardiomyopathy	0.000204	0.00143	CcSEcCtD
Zoledronate—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000204	0.00143	CcSEcCtD
Zoledronate—Headache—Lisinopril—dilated cardiomyopathy	0.000203	0.00142	CcSEcCtD
Zoledronate—Nausea—Lisinopril—dilated cardiomyopathy	0.000192	0.00135	CcSEcCtD
